Researchers in academia and industry have used our first genome-scale Th17 TRN (Ciofani et al. 2012) to develop hypotheses in the context of autoimmunity (Isono et al. 2014; Yang et al. 2014; Patel and Kuchroo 2015). The gene discussed is TNPO1; the disease is Autoimmunity.